Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.
Tagliaferri
P
P
Cattedra di Oncologia Medica, Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Facoltà di Medicina, Università Federico II, Naples, Italy.
Guarrasi
R
R
Caraglia
M
M
Morelli
D
D
Fabbrocini
A
A
Correale
P
P
Bianco
A R
AR
D000818:Animals; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
D016207:Cytokines; D007376:Interleukin-2